Iveda Gets Nasdaq Extension to March 1, 2027 to Regain $1.00 Bid Price Compliance
Nasdaq granted Iveda Solutions an additional 180 calendar days, until March 1, 2027, to regain compliance with its $1.00 minimum bid price rule, after the company requested the extension on September 2, 2026. The extension delays a possible delisting, but the stock must still close at or above $1.00 for at least 10 consecutive business days, and the company has not decided on a reverse stock split.
Key points
- Nasdaq first notified Iveda on March 6, 2026, that its closing bid price had been below $1.00 for 30 consecutive business days.
- Iveda received the second grace period letter from Nasdaq on September 4, 2026, extending the deadline to March 1, 2027.
- Iveda may consider a reverse stock split if appropriate, but has not announced a decision to implement one.
- The company may still be delisted during the period if it fails other Nasdaq listing requirements, and Nasdaq would issue a delisting notice if compliance is not shown by March 1, 2027.
The filing
Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 09, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.